Despite the data supporting an oncogenic role of the IL-1/IL-1R1 axis in HNSCC, there is a lack of studies that have explored the use of IL-1 inhibition for HNSCC treatment. The gene discussed is IL1B; the disease is head and neck squamous cell carcinoma.